TrialJournal of the National Cancer Institute2019

Adjuvant Anti-HER2 Therapy, Treatment-Related Amenorrhea, and Survival in Premenopausal HER2-Positive Early Breast Cancer Patients.

Matteo Lambertini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.